HIGHLIGHTS
- who: Liangyu Kang and collaborators from the School of Public Health, Peking University, Beijing, China have published the research work: Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis, in the Journal: Vaccines 2022, 10, x FOR PEER REVIEW of 28/04/2022
- what: The authors aimed to evaluate the immunogenicity and safety of COVID-19 vaccines among PLWH.
- how: The authors evaluated the risk of bias using the Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) for RCTs Risk Of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.